Imthiaz Manoly
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Imthiaz Manoly has a total of 63 co-authors. Here are the top co-authors by number of shared publications:
- Dimos Karangelis
Department of Cardiothoracic Surgery, University General Hospital, Democritus University of Thrace, 68100 Alexandroupolis, Greece
3 shared publications Ragheb Hasan
Central Manchester University Hospitals Foundation Trust, Manchester, United Kingdom
3 shared publicationsCharles Peebles
2 shared publicationsJ. Andreas Hoschtitzky
Adult Congenital Heart Disease Unit, Central Manchester University Hospitals Foundation Trust, Manchester, United Kingdom
2 shared publicationsMarcus Haw
2 shared publications- Mohsin Uzzaman
Peshawar Institute of Cardiology, Peshawar, Pakistan
2 shared publications
Latest Publications
- Open Access
- 11 February 2026
- Published by IMR Press in The Heart Surgery Forum
- Vol. 29 (2)
Response to ‘Clinical Application of Three Antegrade Cerebral Perfusion Strategies in Acute DeBakey Type I Aortic Dissection’
- 11 February 2026
- Published by IMR Press in The Heart Surgery Forum
- Vol. 29 (2)
Open AccessResponse to ‘Clinical Application of Three Antegrade Cerebral Perfusion Strategies in Acute DeBakey Type I Aortic Dissection’
- 13 July 2025
- Published by BMJ in BMJ Case Reports
- Vol. 18 (7) , e265936
Ventricular electrical storm refractory to 250 defibrillations during myomectomy: the critical role of VA-ECMO and multidisciplinary management
Ventricular electrical storm (VES) is a critical cardiac emergency with high mortality, often refractory to treatment. They are typically associated with certain cardiovascular diseases, cardiac surgeries, hereditary arrhythmia syndromes or ICD shocks. Malignant intraoperative VES during non-cardiac surgeries represents a rare subset within cardiovascular medicine, yet their under-representation in clinical literature is disproportionate to the critical nature of the condition. This case report describes a previously healthy patient who developed sudden intraoperative ventricular fibrillation (VF) during an elective myomectomy, progressing to an overwhelmingly malignant VES. A family history of sudden cardiac death suggested a genetic arrhythmic syndrome. Management required over 250 defibrillations, veno-arterial extracorporeal membrane oxygenation (VA-ECMO), intra-aortic balloon pump (IABP) and a multidisciplinary approach. Despite poor prognostic indicators, the patient survived, an exceptionally rare outcome. This case underscores the importance of early mechanical circulatory support and highlights the potential for recovery even in critical scenarios challenging conventional prognostic expectations.
- 13 July 2025
- Published by BMJ in BMJ Case Reports
- Vol. 18 (7) , e265936
Ventricular electrical storm refractory to 250 defibrillations during myomectomy: the critical role of VA-ECMO and multidisciplinary management
Ventricular electrical storm (VES) is a critical cardiac emergency with high mortality, often refractory to treatment. They are typically associated with certain cardiovascular diseases, cardiac surgeries, hereditary arrhythmia syndromes or ICD shocks. Malignant intraoperative VES during non-cardiac surgeries represents a rare subset within cardiovascular medicine, yet their under-representation in clinical literature is disproportionate to the critical nature of the condition. This case report describes a previously healthy patient who developed sudden intraoperative ventricular fibrillation (VF) during an elective myomectomy, progressing to an overwhelmingly malignant VES. A family history of sudden cardiac death suggested a genetic arrhythmic syndrome. Management required over 250 defibrillations, veno-arterial extracorporeal membrane oxygenation (VA-ECMO), intra-aortic balloon pump (IABP) and a multidisciplinary approach. Despite poor prognostic indicators, the patient survived, an exceptionally rare outcome. This case underscores the importance of early mechanical circulatory support and highlights the potential for recovery even in critical scenarios challenging conventional prognostic expectations.
- 10 August 2024
- Published by Springer Nature in Indian Journal of Thoracic and Cardiovascular Surgery
- Vol. 41 (1) , 111-113
Cardiac surgeons as entrepreneurs: bridging medicine and business for cardiovascular innovation
- 10 August 2024
- Published by Springer Nature in Indian Journal of Thoracic and Cardiovascular Surgery
- Vol. 41 (1) , 111-113
Cardiac surgeons as entrepreneurs: bridging medicine and business for cardiovascular innovation
- 16 January 2023
- Published by Springer Nature in Indian Journal of Surgery
- Vol. 85 (S2) , 405-416
Lung Transplantation in India: a Brief Review, Landmarks, Indian Scenario, and our Experience
Lung transplantation is gaining widespread acceptance as the preferred therapeutic option for selected cases of end-stage lung disease in India. The indications of lung transplantation are increasing, with better post-operative survival, including the COVID affected lung, if we choose our patients well. The national acceptance of expanded criteria in lung donation, streamlining of the process of lung transplantation by governmental, and non-governmental organizations and significant increase in the number of organ donations in India have strengthened the lung transplantation program within the country. Through this article, we describe a brief history, the process, and our experience of lung transplantation since we started our program in 2017 until date.
- 16 January 2023
- Published by Springer Nature in Indian Journal of Surgery
- Vol. 85 (S2) , 405-416
Lung Transplantation in India: a Brief Review, Landmarks, Indian Scenario, and our Experience
Lung transplantation is gaining widespread acceptance as the preferred therapeutic option for selected cases of end-stage lung disease in India. The indications of lung transplantation are increasing, with better post-operative survival, including the COVID affected lung, if we choose our patients well. The national acceptance of expanded criteria in lung donation, streamlining of the process of lung transplantation by governmental, and non-governmental organizations and significant increase in the number of organ donations in India have strengthened the lung transplantation program within the country. Through this article, we describe a brief history, the process, and our experience of lung transplantation since we started our program in 2017 until date.
- Open Access
- 11 January 2022
- Published by SAGE Publications in Asian Cardiovascular and Thoracic Annals
- Vol. 30 (6) , 635-644
Neuroprotective strategies with circulatory arrest in open aortic surgery – A meta-analysis
Deep hypothermic circulatory arrest (DHCA) in aortic surgery is associated with morbidity and mortality despite evolving strategies. With the advent of antegrade cerebral perfusion (ACP), moderate hypothermic circulatory arrest (MHCA) was reported to have better outcomes than DHCA. There is no standardised guideline or consensus regarding the hypothermic strategies to be employed in open aortic surgery. Meta-analysis was performed comparing DHCA with MHCA + ACP in patients having aortic surgery. A systematic review of the literature was undertaken. Any studies with DHCA versus MHCA + ACP in aortic surgeries were selected according to specific inclusion criteria and analysed to generate summative data. Statistical analysis was performed using STATS Direct. The primary outcomes were hospital mortality and post-operative stroke. Secondary outcomes were cardiopulmonary bypass time (CPB), post-operative blood transfusion, length of ICU stay, respiratory complications, renal failure and length of hospital stay. Subgroup analysis of primary outcomes for Arch surgery alone was also performed. Fifteen studies were included with a total of 5869 patients. There was significantly reduced mortality (Pooled OR = +0.64, 95% CI = +0.49 to +0.83; p = 0.0006) and stroke rate (Pooled OR = +0.62, 95% CI = +0.49 to +0.79; p < 0.001) in the MHCA group. MHCA was associated significantly with shorter CPB times, shorter duration in ICU, less pulmonary complications, and reduced rates of sepsis. There was no statistical difference between the two groups in terms of circulatory arrest times, X-Clamp times, total operation duration, transfusion requirements, renal failure and post-op hospital stay. MHCA + ACP are associated with significantly better post-operative outcomes compared with DHCA for both mortality and stroke and majority of the secondary outcomes.
- 11 January 2022
- Published by SAGE Publications in Asian Cardiovascular and Thoracic Annals
- Vol. 30 (6) , 635-644
Open AccessNeuroprotective strategies with circulatory arrest in open aortic surgery – A meta-analysis
Deep hypothermic circulatory arrest (DHCA) in aortic surgery is associated with morbidity and mortality despite evolving strategies. With the advent of antegrade cerebral perfusion (ACP), moderate hypothermic circulatory arrest (MHCA) was reported to have better outcomes than DHCA. There is no standardised guideline or consensus regarding the hypothermic strategies to be employed in open aortic surgery. Meta-analysis was performed comparing DHCA with MHCA + ACP in patients having aortic surgery. A systematic review of the literature was undertaken. Any studies with DHCA versus MHCA + ACP in aortic surgeries were selected according to specific inclusion criteria and analysed to generate summative data. Statistical analysis was performed using STATS Direct. The primary outcomes were hospital mortality and post-operative stroke. Secondary outcomes were cardiopulmonary bypass time (CPB), post-operative blood transfusion, length of ICU stay, respiratory complications, renal failure and length of hospital stay. Subgroup analysis of primary outcomes for Arch surgery alone was also performed. Fifteen studies were included with a total of 5869 patients. There was significantly reduced mortality (Pooled OR = +0.64, 95% CI = +0.49 to +0.83; p = 0.0006) and stroke rate (Pooled OR = +0.62, 95% CI = +0.49 to +0.79; p < 0.001) in the MHCA group. MHCA was associated significantly with shorter CPB times, shorter duration in ICU, less pulmonary complications, and reduced rates of sepsis. There was no statistical difference between the two groups in terms of circulatory arrest times, X-Clamp times, total operation duration, transfusion requirements, renal failure and post-op hospital stay. MHCA + ACP are associated with significantly better post-operative outcomes compared with DHCA for both mortality and stroke and majority of the secondary outcomes.
- Open Access
- 27 May 2021
- Published by Wiley
SURGICAL TREATMENT OF ATRIAL FIBRILLATION IN ELDERLY PATIENTS UNDERGOING HIGH RISK CARDIAC SURGERY
BACKGROUND/AIM To evaluate outcomes of concurrent Cox-Maze procedures in elderly patients undergoing high-risk cardiac surgery. MEHODS We retrospectively identified patients aged over 70 years with Atrial Fibrillation (AF) from 2011 to 2017 who had two or more other cardiac procedures. They were subdivided into two groups: 1. Cox-Maze IV AF ablation 2. No-Surgical AF treatment. Patients requiring redo procedures or those who had isolated PVI or LAAO were excluded. Heart rhythm assessed from Holter reports or 12-lead ECG. Follow-up data collected through telephone consultations and medical records. RESULTS There were 239 patients. Median follow up was 61 months. 70 patients had Cox-Maze IV procedures (29.3%). Demographic, intra- and post-operative outcomes were similar between groups although duration of pre-operative AF was shorter in Cox-Maze group (p=0.001). One (1.4%) patient in Cox maze group with 30-day mortality compared to 14 (8.2%) the control group (p=0.05). Sinus rhythm at annual and latest follow-up was 84.9% and 80.0% respectively in Maze group - significantly better than No-Surgical AF treatment groups (P<0.001). 160 patients (66.9%) were alive at long-term follow-up with better survival curves in Cox Maze group compared to No-Surgical treatment group (p=0.02). There was significantly higher proportion of patients in NYHA 1 status in Cox-Maze group (p=0.009). No differences observed in freedom from stroke (p=0.80) or permanent pacemaker (p=0.33). CONCLUSIONS. Surgical ablation is beneficial in elderly patients undergoing high-risk surgery - promoting excellent long-term freedom from AF and symptomatic/prognostic benefits. Therefore, surgical risk need not be reason to deny benefits of concomitant AF-ablation.
- 27 May 2021
- Published by Wiley
Open AccessSURGICAL TREATMENT OF ATRIAL FIBRILLATION IN ELDERLY PATIENTS UNDERGOING HIGH RISK CARDIAC SURGERY
BACKGROUND/AIM To evaluate outcomes of concurrent Cox-Maze procedures in elderly patients undergoing high-risk cardiac surgery. MEHODS We retrospectively identified patients aged over 70 years with Atrial Fibrillation (AF) from 2011 to 2017 who had two or more other cardiac procedures. They were subdivided into two groups: 1. Cox-Maze IV AF ablation 2. No-Surgical AF treatment. Patients requiring redo procedures or those who had isolated PVI or LAAO were excluded. Heart rhythm assessed from Holter reports or 12-lead ECG. Follow-up data collected through telephone consultations and medical records. RESULTS There were 239 patients. Median follow up was 61 months. 70 patients had Cox-Maze IV procedures (29.3%). Demographic, intra- and post-operative outcomes were similar between groups although duration of pre-operative AF was shorter in Cox-Maze group (p=0.001). One (1.4%) patient in Cox maze group with 30-day mortality compared to 14 (8.2%) the control group (p=0.05). Sinus rhythm at annual and latest follow-up was 84.9% and 80.0% respectively in Maze group - significantly better than No-Surgical AF treatment groups (P<0.001). 160 patients (66.9%) were alive at long-term follow-up with better survival curves in Cox Maze group compared to No-Surgical treatment group (p=0.02). There was significantly higher proportion of patients in NYHA 1 status in Cox-Maze group (p=0.009). No differences observed in freedom from stroke (p=0.80) or permanent pacemaker (p=0.33). CONCLUSIONS. Surgical ablation is beneficial in elderly patients undergoing high-risk surgery - promoting excellent long-term freedom from AF and symptomatic/prognostic benefits. Therefore, surgical risk need not be reason to deny benefits of concomitant AF-ablation.
- Open Access
- 29 March 2021
- Published by Wiley in Clinical Case Reports
- Vol. 9 (8) , e04085
Aortic valve replacement in a patient with sickle cell disease—Are we justified to perform surgery in the TAVI era?
Not all variants of SCD need the same management and this should be decided on a case‐by‐case basis. Heterozygous SCD patients can undergo cardiac surgery without the need for intraoperative exchange transfusions with good clinical outcomes.
- 29 March 2021
- Published by Wiley in Clinical Case Reports
- Vol. 9 (8) , e04085
Open AccessAortic valve replacement in a patient with sickle cell disease—Are we justified to perform surgery in the TAVI era?
Not all variants of SCD need the same management and this should be decided on a case‐by‐case basis. Heterozygous SCD patients can undergo cardiac surgery without the need for intraoperative exchange transfusions with good clinical outcomes.
- 12 July 2016
- Published by Wiley in Catheterization and Cardiovascular Interventions
- Vol. 89 (7) , 1273-1279
Feasibility of hybrid off pump artery bypass grafting and transaortic transcatheter aortic valve implantation: A case series
Introduction: Patients with complex coronary artery disease and severe aortic stenosis unsuitable for conventional cardiac surgery pose a significant treatment challenge. This is especially difficult for patients where percutaneous revascularization is technically very challenging and/or would not offer as complete revascularisation compared to surgical revascularisation. In addition, patients who are unsuitable for transfemoral transcatheter aortic valve implantation (TAVI) pose an additional technical challenge, particularly with dual antiplatelet therapy (DAPT) following percutaneous coronary intervention (PCI). As a potential solution we describe the first case series of hybrid off‐pump coronary artery bypass grafting (CABG) combined with transaortic TAVI.Methods and results: Over a ten‐month‐period, four patients underwent hybrid off‐pump CABG combined with transaortic TAVI. A full sternotomy allowed off‐pump arterial and vein graft anastomosis to significantly stenosed coronaries. The first three patients had severe aorto‐iliac disease precluding femoral access; the fourth patient was deemed unsuitable for PCI. Transaortic TAVI using Edwards Sapien 3 valves were performed without complication in all four patients.Conclusion: The hybrid off‐pump CABG and transaortic TAVI procedure allows for more complete coronary revascularization, negates the need for DAPT, and minimizes treatment delay of a TAVI procedure, particularly in patients unsuitable for transfemoral access. We propose this as an important treatment option for the heart team to consider.
- 12 July 2016
- Published by Wiley in Catheterization and Cardiovascular Interventions
- Vol. 89 (7) , 1273-1279
Feasibility of hybrid off pump artery bypass grafting and transaortic transcatheter aortic valve implantation: A case series
Introduction: Patients with complex coronary artery disease and severe aortic stenosis unsuitable for conventional cardiac surgery pose a significant treatment challenge. This is especially difficult for patients where percutaneous revascularization is technically very challenging and/or would not offer as complete revascularisation compared to surgical revascularisation. In addition, patients who are unsuitable for transfemoral transcatheter aortic valve implantation (TAVI) pose an additional technical challenge, particularly with dual antiplatelet therapy (DAPT) following percutaneous coronary intervention (PCI). As a potential solution we describe the first case series of hybrid off‐pump coronary artery bypass grafting (CABG) combined with transaortic TAVI.Methods and results: Over a ten‐month‐period, four patients underwent hybrid off‐pump CABG combined with transaortic TAVI. A full sternotomy allowed off‐pump arterial and vein graft anastomosis to significantly stenosed coronaries. The first three patients had severe aorto‐iliac disease precluding femoral access; the fourth patient was deemed unsuitable for PCI. Transaortic TAVI using Edwards Sapien 3 valves were performed without complication in all four patients.Conclusion: The hybrid off‐pump CABG and transaortic TAVI procedure allows for more complete coronary revascularization, negates the need for DAPT, and minimizes treatment delay of a TAVI procedure, particularly in patients unsuitable for transfemoral access. We propose this as an important treatment option for the heart team to consider.
- 1 December 2015
- Published by Elsevier in JACC: Cardiovascular Interventions
- Vol. 8 (15) , e247-e249
2-Year Follow-Up of the First in Human Transapical Implantation of Transcatheter Inverted Aortic Valve to Treat Native Mitral Valve Stenosis
- 1 December 2015
- Published by Elsevier in JACC: Cardiovascular Interventions
- Vol. 8 (15) , e247-e249
2-Year Follow-Up of the First in Human Transapical Implantation of Transcatheter Inverted Aortic Valve to Treat Native Mitral Valve Stenosis